M&A

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Shots: Paratek has entered into a definitive merger agreement to acquire Optinose...

Taiho Pharmaceutical to Acquire Araris Biotech for ~$1.1B

Taiho Pharmaceutical to Acquire Araris Biotech for ~$1.1B

Shots: Taiho Pharmaceutical has entered into a definitive agreement to acquire Ara...

Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

Shots: Mallinckrodt & Endo to combine their generic pharmaceuticals & Endo...

AstraZeneca to acquire EsoBiotec for ~$1B

AstraZeneca to acquire EsoBiotec for ~$1B

Shots: AstraZeneca to acquire EsoBiotec, which will operate as AstraZeneca’s...

Sun Pharma to Acquire Checkpoint Therapeutics For ~$355M

Sun Pharma to Acquire Checkpoint Therapeutics For ~$355M

Shots: Sun Pharma to acquire Checkpoint Therapeutics for ~$355M to strengthen its...

Jazz Pharmaceuticals to Acquire Chimerix for ~$935M

Jazz Pharmaceuticals to Acquire Chimerix for ~$935M

Shots: Jazz Pharmaceuticals to acquire Chimerix for ~$935M at a price of $8.55 per...

Image